177 related articles for article (PubMed ID: 17184209)
1. Search for shortcuts on the critical path to market: US FDA perspectives from the diagnostic side.
Gutman S; Hackett J
Pharmacogenomics; 2006 Dec; 7(8):1223-7. PubMed ID: 17184209
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
3. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
4. Molecular biomarkers: a US FDA effort.
Hong H; Goodsaid F; Shi L; Tong W
Biomark Med; 2010 Apr; 4(2):215-25. PubMed ID: 20406066
[TBL] [Abstract][Full Text] [Related]
5. Biomarker qualification pilot process at the US Food and Drug Administration.
Goodsaid F; Frueh F
AAPS J; 2007 Mar; 9(1):E105-8. PubMed ID: 17408233
[TBL] [Abstract][Full Text] [Related]
6. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
7. FDA marketing claims, and the practitioner.
Runner S
J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
[TBL] [Abstract][Full Text] [Related]
8. Introduction to the Food and Drug Administration (FDA) regulatory process.
Hackett JL; Gutman SI
J Proteome Res; 2005; 4(4):1110-3. PubMed ID: 16083260
[TBL] [Abstract][Full Text] [Related]
9. US manufacturing guideline for IVD products.
Donawa M
Med Device Technol; 2000 Oct; 11(8):23-4. PubMed ID: 11185183
[TBL] [Abstract][Full Text] [Related]
10. The US Food and Drug Administration perspective on cancer biomarker development.
Gutman S; Kessler LG
Nat Rev Cancer; 2006 Jul; 6(7):565-71. PubMed ID: 16794639
[TBL] [Abstract][Full Text] [Related]
11. What's next after 50 years of psychiatric drug development: an FDA perspective.
Laughren TP
J Clin Psychiatry; 2010 Sep; 71(9):1196-204. PubMed ID: 20923624
[TBL] [Abstract][Full Text] [Related]
12. A drug's life: the pathway to drug approval.
Keng MK; Wenzell CM; Sekeres MA
Clin Adv Hematol Oncol; 2013 Oct; 11(10):646-55. PubMed ID: 24518374
[TBL] [Abstract][Full Text] [Related]
13. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
14. Medical devices; classification/reclassification of immunohistochemistry reagents and kits--FDA. Final rule.
Fed Regist; 1998 Jun; 63(106):30132-42. PubMed ID: 10179865
[TBL] [Abstract][Full Text] [Related]
15. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
Reeve LM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
[TBL] [Abstract][Full Text] [Related]
16. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
[TBL] [Abstract][Full Text] [Related]
18. Approval of novel biomarkers: FDA's perspective and major requests.
Scherf U; Becker R; Chan M; Hojvat S
Scand J Clin Lab Invest Suppl; 2010; 242():96-102. PubMed ID: 20515286
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects in women: implications for drug development and regulatory policies.
Parekh A; Fadiran EO; Uhl K; Throckmorton DC
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):453-66. PubMed ID: 22114855
[TBL] [Abstract][Full Text] [Related]
20. Food and Drug Administration approval process for ophthalmic drugs in the US.
Lloyd R; Harris J; Wadhwa S; Chambers W
Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
